Found: 40
Select item for more details and to access through your institution.
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad069
- By:
- Publication type:
- Article
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12423-x
- By:
- Publication type:
- Article
Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development.
- Published in:
- Biotechnology Progress, 2022, v. 38, n. 6, p. 1, doi. 10.1002/btpr.3296
- By:
- Publication type:
- Article
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26579-z
- By:
- Publication type:
- Article
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.
- Published in:
- Nature Medicine, 2015, v. 21, n. 11, p. 1332, doi. 10.1038/nm.3963
- By:
- Publication type:
- Article
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env.
- Published in:
- Nature Structural & Molecular Biology, 2015, v. 22, n. 7, p. 522, doi. 10.1038/nsmb.3051
- By:
- Publication type:
- Article
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 804, doi. 10.1038/nsmb.2600
- By:
- Publication type:
- Article
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42098-5
- By:
- Publication type:
- Article
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39265-z
- By:
- Publication type:
- Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
- By:
- Publication type:
- Article
Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8<sup>+</sup> T Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031464
- By:
- Publication type:
- Article
HIV Neutralizing Antibodies: Clinical Correlates and Implications for Vaccines.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07851-1
- By:
- Publication type:
- Article
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 4, p. 1, doi. 10.1371/journal.ppat.1007632
- By:
- Publication type:
- Article
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.ppat.1007024
- By:
- Publication type:
- Article
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2.
- Published in:
- Advanced Science, 2022, v. 9, n. 15, p. 1, doi. 10.1002/advs.202200063
- By:
- Publication type:
- Article
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.
- Published in:
- Immunological Reviews, 2017, v. 275, n. 1, p. 217, doi. 10.1111/imr.12501
- By:
- Publication type:
- Article
Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50635-w
- By:
- Publication type:
- Article
Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0225806
- By:
- Publication type:
- Article
Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 520, p. 1, doi. 10.1126/scitranslmed.aax0904
- By:
- Publication type:
- Article
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 406, p. 1, doi. 10.1126/scitranslmed.aal1321
- By:
- Publication type:
- Article
Multigene DNA prime-boost vaccines for SHIV89.6P.
- Published in:
- Journal of Medical Primatology, 2003, v. 32, n. 4/5, p. 218, doi. 10.1034/j.1600-0684.2003.00028.x
- By:
- Publication type:
- Article
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004932
- By:
- Publication type:
- Article
Cytotoxic Capacity of SIV-Specific CD8<sup>+</sup> T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 2, p. 1, doi. 10.1371/journal.ppat.1003195
- By:
- Publication type:
- Article
Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 2, p. 23, doi. 10.3390/antib10020023
- By:
- Publication type:
- Article
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 1, p. 1, doi. 10.1371/journal.ppat.1006148
- By:
- Publication type:
- Article
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.
- Published in:
- Nature, 2014, v. 515, n. 7525, p. 138, doi. 10.1038/nature13601
- By:
- Publication type:
- Article
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
- Published in:
- Nature, 2014, v. 509, n. 7498, p. 55, doi. 10.1038/nature13036
- By:
- Publication type:
- Article
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
- Published in:
- Nature, 2012, v. 491, n. 7424, p. 406, doi. 10.1038/nature11544
- By:
- Publication type:
- Article
IDENTIFICATION OF HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES TARGETING MPER.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 121
- By:
- Publication type:
- Article
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06424-6
- By:
- Publication type:
- Article
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03335-4
- By:
- Publication type:
- Article
RAIN: machine learning-based identification for HIV-1 bNAbs.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49676-1
- By:
- Publication type:
- Article
RAIN: machine learning-based identification for HIV-1 bNAbs.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49676-1
- By:
- Publication type:
- Article
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48514-8
- By:
- Publication type:
- Article
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215163
- By:
- Publication type:
- Article
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 6, p. 1, doi. 10.1371/journal.ppat.1010574
- By:
- Publication type:
- Article